Trimethobenzamide

Brand names: Tigan
Drug class: Antineoplastic Agents

Usage of Trimethobenzamide

Nausea and Vomiting

Control of nausea and vomiting, including treatment of postoperative nausea and vomiting.

Treatment of nausea associated with gastroenteritis.

Less effective than phenothiazines, but may be associated with fewer adverse effects.

Relate drugs

How to use Trimethobenzamide

Administration

Administer orally or by IM injection.

Not recommendedfor IV administration.

Preparation for rectal administration is no longer commercially available in the US; FDA has withdrawn approval of the new drug application (NDA) for the rectal suppositories because of lack of substantial evidence of efficacy. (See Preparations.)

IM Administration

Minimize local adverse effects by injecting deep into the upper outer quadrant of the gluteus maximus; avoid local infiltration of the solution along the needle track.

Dosage

Available as trimethobenzamide hydrochloride; dosage expressed in terms of the salt.

Pediatric Patients

Nausea and Vomiting Oral

Children weighing 13.6–45 kg: 100 or 200 mg 3 or 4 times daily; alternatively, children may receive 15–20 mg/kg daily given in 3 or 4 divided doses. However, suitable oral dosage forms are no longer commercially available in the US.

Adults

Nausea and Vomiting Oral

Usual dosage: 300 mg 3 or 4 times daily. Adjust dosage according to indication for use, severity of symptoms, and patient response.

IM

Usual dosage: 200 mg 3 or 4 times daily. Adjust dosage according to indication for use, severity of symptoms, and patient response.

Special Populations

No special population dosage recommendations at this time.

Warnings

Contraindications

  • Known hypersensitivity to trimethobenzamide.
  • Injection contraindicated in children.

    • Warnings/Precautions

    Warnings

    CNS Depression

    May impair ability to perform activities requiring mental alertness or physical coordination (e.g., operating machinery, driving a motor vehicle); avoid concomitant use with alcohol.

    Neurologic Effects

    Possible neurologic reactions (e.g., opisthotonos, seizures, coma, extrapyramidal reactions); may be similar to CNS signs and symptoms accompanying certain disorders (e.g., acute febrile illness, encephalitis, Reye’s syndrome, encephalopathy, gastroenteritis, dehydration, electrolyte imbalance), especially in children and in geriatric or debilitated patients. Diagnosis of these disorders may be obscured or the disease-associated signs and symptoms may be incorrectly diagnosed as drug induced.

    Use with caution in patients with such disorders, particularly in those who have recently received other CNS drugs (e.g., phenothiazines, barbiturates, Belladonna derivatives). (See Specific Drugs under Interactions.)

    Avoid use in pediatric patients with signs and symptoms suggestive of Reye’s syndrome. (See Pediatric Use under Cautions.)

    Discontinue drug if CNS symptoms occur.

    Sensitivity Reactions

    Hypersensitivity Reactions

    Hypersensitivity reactions including allergic skin reactions have been reported; discontinue at the first sign of sensitization.

    General Precautions

    Hepatic Effects

    Jaundice reported; discontinue drug if jaundice occurs.

    Potential hepatotoxic effects may unfavorably alter the course of Reye’s syndrome. (See Pediatric Use under Cautions.)

    Hematologic Effects

    Blood dyscrasias reported; discontinue drug if blood dyscrasia occurs.

    GI Effects

    Antiemetic effect may mask signs of overdosage of other drugs or may obscure the cause of vomiting in various disorders (e.g., appendicitis).

    Discontinue drug if exaggeration of preexisting nausea occurs.

    Specific Populations

    Pregnancy

    Category C.

    Lactation

    Not known whether trimethobenzamide is distributed into milk. Safety not established.

    Pediatric Use

    Injection contraindicated in children. Suitable oral dosage forms and rectal suppositories for pediatric use no longer are commercially available in the US. (See Preparations.)

    Use trimethobenzamide with caution in children. Not recommended for treatment of uncomplicated vomiting in children; limit use to treatment of prolonged vomiting of known etiology. Avoid use in pediatric patients with signs and symptoms suggestive of Reye’s syndrome.

    Extrapyramidal effects of trimethobenzamide may obscure the diagnosis of or be confused with CNS manifestations of Reye’s syndrome or other encephalopathies. (See Neurologic Effects under Cautions.)

    Potential hepatotoxic effects of trimethobenzamide may unfavorably alter the course of Reye’s syndrome.

    Children with acute febrile illnesses, encephalitides, gastroenteritis, dehydration, or electrolyte imbalance may be at increased risk for adverse CNS effects (e.g., extrapyramidal reactions, opisthotonos, seizures, coma). Use with caution in such children, especially those who recently have received other CNS agents.

    Geriatric Use

    Geriatric and debilitated patients with acute febrile illnesses, encephalitides, gastroenteritis, dehydration, or electrolyte imbalance may be at increased risk for adverse CNS effects (e.g., extrapyramidal reactions, opisthotonos, seizures, coma). Use with caution in such individuals, especially those who recently have received other CNS agents.

    Common Adverse Effects

    Adverse effects may include blurred vision, depression, disorientation, dizziness, drowsiness, headache, extrapyramidal symptoms, diarrhea, opisthotonos, and muscle cramps. In addition, injection site reactions (pain, stinging, redness, swelling ) and hypotension may occur following IM injection.

    What other drugs will affect Trimethobenzamide

    Specific Drugs

    Drug

    Interaction

    Comments

    Alcohol

    Impaired mental alertness/physical coordination

    Avoid concomitant use

    CNS drugs (e.g., barbiturates, belladonna derivatives, phenothiazines)

    Possible increased risk of CNS reactions

    Use with caution

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords

    AI Assitant